Randomised Phase III trials with large patient groups

We conduct randomised Phase III trials with large populations and a broad spectrum of therapy areas.

Our model has been crafted to support our sponsors’ needs in the latter stages of drug development.

x

Examples of Richmond’s accelerated patient recruitment

Number one recruitment site out of 83 centres for a study involving patients with Transthyretin Amyloidosis with Cardiomyopathy. 64 patients were recruited within three months.

Richmond recruited 10% of the total patient volunteers needed for a global heart failure trial in just two months.

We are experts in conducting randomised Phase III clinical trials.

Our specialist clinical team has experience in conducting clinical trials with a broad spectrum of patient groups with common and rare diseases.

Get in touch today

Why choose Richmond Pharmacology for Phase III Clinical Trials

TAP OR CLICK A BLOCK BELOW TO LEARN MORE

Single centre studies

We are equipped to deliver single centre studies for early phase patient trials.

Read more +

Multi-disciplined teams

We have access to specialist consultants, professors and medical practitioners through our academic and medical partnerships.

Read more +

Hospital-style setting

Our multi-disciplinary team operate in a hospital-style setting which facilitates efficient, safe trial management.

Read more +

We maintain a 100% retention rate for patients in your study thanks to the engaged and responsive volunteer recruitment project managers.

Latest news

Characterisation of the Cardiovascular Effects of a Meal: QTcF Assessment and Further Insights into the Physiological Effects

December 4, 2023
Groundbreaking research paper authored by Dr. Georg Ferber, Dr. Dilshat Djumanov, Dr. Ulrike Lorch, Dr. Edward Jackson, Dr. Joao Almeida Melo, Mr. James Rickard, and Dr. Jorg Taubel. 
Read more

Richmond Pharmacology becomes Richmond in Brand Refresh

December 1, 2023
Refreshed brand reflects company’s growth over 22 years and renewed commitment to turning hope into reality for patients.
Read more

Events

The 44th Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

14 – 16 December 2023
We are thrilled to share our participation in the 44th Annual Meeting of the Japan Society of Clinical Pharmacology.
View event